Audience asks whether Mutant can be used to identify the subjects with the most mutations so the team can prioritize improving their tests. Schirp has never needed this himself — in commercial work everything gets touched within ~12 months so incremental mode suffices — but it is conceptually possible. He argues the mutation count per subject is a better complexity metric than cyclomatic complexity.